Login / Signup
Novel Plasma Kallikrein Inhibitors for Treating Hereditary Angioedema, Diabetic Macular Edema, and Diabetic Retinopathy.
Rachel Mata
Published in:
ACS medicinal chemistry letters (2022)
Keyphrases
</>
diabetic retinopathy
optical coherence tomography
angiotensin converting enzyme
angiotensin ii